Immunoglobulin M anti-hepatitis D virus in monitoring chronic hepatitis delta

Liver International

Volumn 31, Issue 10, 2011, Pages 1598-1598

  Poggio, Paolo D ^a   Colombo, Silvia ^a   Zaccanelli, Maurizio ^a   Rosti, Alberto ^a  

^a TREVIGLIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS DELTA ANTIGEN; IMMUNOGLOBULIN M; PEGINTERFERON ALPHA2A; VIRUS ANTIBODY; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; ANTIVIRAL THERAPY; CHRONIC HEPATITIS; CLINICAL ARTICLE; DELTA AGENT HEPATITIS; DISEASE MARKER; FOLLOW UP; HEPATITIS DELTA VIRUS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; LIVER BIOPSY; OUTCOME ASSESSMENT; PATIENT MONITORING; TREATMENT DURATION; TREATMENT RESPONSE;

ANTIVIRAL AGENTS; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS;

EID: 80053937527     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02518.x     Document Type: Letter

References (4)

1. Wedemeyer H. Hepatitis D revival. Liver Int 2011; 31(Suppl. 1): 140-4.
2. Wedemeyer H, Yurdaydin C, Dalekos G, et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 2011; 364: 322-31.
3. Glenn J. Hepatitis D virus: the virus, disease and therapy. AASLD Postgraduate Course Syllabus 2010; 56-62.
4. Borghesio E, Rosina F, Smedile A, et al. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon treated patients. Hepatology 1998; 27: 873-6.